Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1994 May;62(5):2126–2128. doi: 10.1128/iai.62.5.2126-2128.1994

Patient cytokine response in transfusion-associated sepsis.

S K McAllister 1, L A Bland 1, M J Arduino 1, S M Aguero 1, P N Wenger 1, W R Jarvis 1
PMCID: PMC186480  PMID: 8168982

Abstract

Cytokine concentrations in plasma from patients transfused with packed erythrocytes contaminated with gram-negative bacilli were measured. Cytokine concentrations in posttransfusion plasma were significantly elevated. A difference in cytokine patterns between survivors and a nonsurvivor was observed.

Full text

PDF
2128

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arduino M. J., Bland L. A., Tipple M. A., Aguero S. M., Favero M. S., Jarvis W. R. Growth and endotoxin production of Yersinia enterocolitica and Enterobacter agglomerans in packed erythrocytes. J Clin Microbiol. 1989 Jul;27(7):1483–1485. doi: 10.1128/jcm.27.7.1483-1485.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bone R. C., Fisher C. J., Jr, Clemmer T. P., Slotman G. J., Metz C. A., Balk R. A. Sepsis syndrome: a valid clinical entity. Methylprednisolone Severe Sepsis Study Group. Crit Care Med. 1989 May;17(5):389–393. [PubMed] [Google Scholar]
  3. Calandra T., Baumgartner J. D., Grau G. E., Wu M. M., Lambert P. H., Schellekens J., Verhoef J., Glauser M. P. Prognostic values of tumor necrosis factor/cachectin, interleukin-1, interferon-alpha, and interferon-gamma in the serum of patients with septic shock. Swiss-Dutch J5 Immunoglobulin Study Group. J Infect Dis. 1990 May;161(5):982–987. doi: 10.1093/infdis/161.5.982. [DOI] [PubMed] [Google Scholar]
  4. Calandra T., Glauser M. P. Cytokines and septic shock. Diagn Microbiol Infect Dis. 1990 Sep-Oct;13(5):377–381. doi: 10.1016/0732-8893(90)90006-h. [DOI] [PubMed] [Google Scholar]
  5. Creasey A. A., Stevens P., Kenney J., Allison A. C., Warren K., Catlett R., Hinshaw L., Taylor F. B., Jr Endotoxin and cytokine profile in plasma of baboons challenged with lethal and sublethal Escherichia coli. Circ Shock. 1991 Feb;33(2):84–91. [PubMed] [Google Scholar]
  6. Dofferhoff A. S., Bom V. J., van Ingen J., de Vries-Hospers H. G., Hazenberg B. P., van der Meer J., Mulder P. O., Weits J. Patterns of cytokines, plasma endotoxin, and acute phase proteins during the treatment of severe sepsis in humans. Prog Clin Biol Res. 1991;367:43–54. [PubMed] [Google Scholar]
  7. Dofferhoff A. S., Vellenga E., Limburg P. C., van Zanten A., Mulder P. O., Weits J. Tumour necrosis factor (cachectin) and other cytokines in septic shock: a review of the literature. Neth J Med. 1991 Aug;39(1-2):45–62. [PubMed] [Google Scholar]
  8. Exley A. R., Cohen J., Buurman W., Owen R., Hanson G., Lumley J., Aulakh J. M., Bodmer M., Riddell A., Stephens S. Monoclonal antibody to TNF in severe septic shock. Lancet. 1990 May 26;335(8700):1275–1277. doi: 10.1016/0140-6736(90)91337-a. [DOI] [PubMed] [Google Scholar]
  9. Hack C. E., De Groot E. R., Felt-Bersma R. J., Nuijens J. H., Strack Van Schijndel R. J., Eerenberg-Belmer A. J., Thijs L. G., Aarden L. A. Increased plasma levels of interleukin-6 in sepsis. Blood. 1989 Oct;74(5):1704–1710. [PubMed] [Google Scholar]
  10. Halstensen A., Ceska M., Brandtzaeg P., Redl H., Naess A., Waage A. Interleukin-8 in serum and cerebrospinal fluid from patients with meningococcal disease. J Infect Dis. 1993 Feb;167(2):471–475. doi: 10.1093/infdis/167.2.471. [DOI] [PubMed] [Google Scholar]
  11. Hinshaw L. B., Tekamp-Olson P., Chang A. C., Lee P. A., Taylor F. B., Jr, Murray C. K., Peer G. T., Emerson T. E., Jr, Passey R. B., Kuo G. C. Survival of primates in LD100 septic shock following therapy with antibody to tumor necrosis factor (TNF alpha). Circ Shock. 1990 Mar;30(3):279–292. [PubMed] [Google Scholar]
  12. Kreger B. E., Craven D. E., Carling P. C., McCabe W. R. Gram-negative bacteremia. III. Reassessment of etiology, epidemiology and ecology in 612 patients. Am J Med. 1980 Mar;68(3):332–343. doi: 10.1016/0002-9343(80)90101-1. [DOI] [PubMed] [Google Scholar]
  13. Michie H. R., Guillou P. J., Wilmore D. W. Tumour necrosis factor and bacterial sepsis. Br J Surg. 1989 Jul;76(7):670–671. doi: 10.1002/bjs.1800760706. [DOI] [PubMed] [Google Scholar]
  14. Morrison D. C., Ulevitch R. J. The effects of bacterial endotoxins on host mediation systems. A review. Am J Pathol. 1978 Nov;93(2):526–618. [PMC free article] [PubMed] [Google Scholar]
  15. Pinsky M. R., Vincent J. L., Deviere J., Alegre M., Kahn R. J., Dupont E. Serum cytokine levels in human septic shock. Relation to multiple-system organ failure and mortality. Chest. 1993 Feb;103(2):565–575. doi: 10.1378/chest.103.2.565. [DOI] [PubMed] [Google Scholar]
  16. Powell A. C., Bland L. E., Oettinger C. W., McAllister S. K., Oliver J. C., Arduino M. J., Favero M. S. Lack of plasma interleukin-1 beta or tumor necrosis factor-alpha elevation during unfavorable hemodialysis conditions. J Am Soc Nephrol. 1991 Nov;2(5):1007–1013. doi: 10.1681/ASN.V251007. [DOI] [PubMed] [Google Scholar]
  17. Rietschel E. T., Schade U., Jensen M., Wollenweber H. W., Lüderitz O., Greisman S. G. Bacterial endotoxins: chemical structure, biological activity and role in septicaemia. Scand J Infect Dis Suppl. 1982;31:8–21. [PubMed] [Google Scholar]
  18. Tipple M. A., Bland L. A., Murphy J. J., Arduino M. J., Panlilio A. L., Farmer J. J., 3rd, Tourault M. A., Macpherson C. R., Menitove J. E., Grindon A. J. Sepsis associated with transfusion of red cells contaminated with Yersinia enterocolitica. Transfusion. 1990 Mar-Apr;30(3):207–213. doi: 10.1046/j.1537-2995.1990.30390194338.x. [DOI] [PubMed] [Google Scholar]
  19. Tracey K. J. Tumor necrosis factor (cachectin) in the biology of septic shock syndrome. Circ Shock. 1991 Oct;35(2):123–128. [PubMed] [Google Scholar]
  20. Waage A., Aasen A. O. Different role of cytokine mediators in septic shock related to meningococcal disease and surgery/polytrauma. Immunol Rev. 1992 Jun;127:221–230. doi: 10.1111/j.1600-065x.1992.tb01416.x. [DOI] [PubMed] [Google Scholar]
  21. Waage A., Brandtzaeg P., Halstensen A., Kierulf P., Espevik T. The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6, interleukin 1, and fatal outcome. J Exp Med. 1989 Jan 1;169(1):333–338. doi: 10.1084/jem.169.1.333. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Waage A., Halstensen A., Espevik T. Association between tumour necrosis factor in serum and fatal outcome in patients with meningococcal disease. Lancet. 1987 Feb 14;1(8529):355–357. doi: 10.1016/s0140-6736(87)91728-4. [DOI] [PubMed] [Google Scholar]
  23. Ziegler E. J., Fisher C. J., Jr, Sprung C. L., Straube R. C., Sadoff J. C., Foulke G. E., Wortel C. H., Fink M. P., Dellinger R. P., Teng N. N. Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. The HA-1A Sepsis Study Group. N Engl J Med. 1991 Feb 14;324(7):429–436. doi: 10.1056/NEJM199102143240701. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES